FDA & CDC Authorize COVID-19 Boosters for Eligible Individuals

Vaccine vial

Updated 1/18/22

 

FDA & CDC Authorize COVID-19 Boosters for Eligible Individuals

 

Boosters have been approved for all 3 COVID-19 vaccines (Pfizer, Moderna and Johnson & Johnson). 
Boosters for 12-15 year olds are authorized and available for online scheduling.

 

Schedule an appointment today.

 

Boosters

The FDA and CDC have authorized COVID-19 boosters for Pfizer, Moderna and Johnson & Johnson recipients who meet the below criteria. See below for information on boosters as well as additional doses for moderately to severely immunocompromised individuals. What’s the difference between a booster and an additional dose?

 

Pfizer:

Boosters can be administered at least 5 months after the 2nd dose of an initial series of Pfizer for individuals 12 years or older. Individuals 12-17 are only eligible for a Pfizer booster dose (no mixing and matching).  Online scheduling for booster doses for individuals 12-15 coming soon.

 

Moderna:

Boosters can be administered at least 5 months after the 2nd dose of an initial series of Moderna or individuals 18 years or older. Moderna boosters will be administered at a half-dose volume compared to the initial series.

 

Johnson & Johnson/Janssen:

Boosters can be administered at least 2 months after the initial Johnson & Johnson/Janssen shot was administered for anyone age 18+. mRNA boosters (Pfizer or Moderna) are recommended over an additional dose of Johnson & Johnson/Janssen.

 

Can I choose a different vaccine for a booster (mix and match):

The CDC recommends a mRNA (Pfizer or Moderna) vaccine for your booster. Currently you can schedule a booster for the same vaccine you received for your initial series. If a different one is preferred, please talk to your pharmacist at the time of your appointment. Individuals 12-17 may only get a Pfizer booster. 

 

Additional Doses for Immunocompromised

To meet the qualifications for an additional dose

  • Individuals must have received the original series of either Pfizer or Moderna COVID-19 vaccine at least 28 days prior

 

AND be considered moderately to severely immunocompromised as defined below:

  • Had a solid organ transplant or recent hematopoietic malignancies

  • Active or recent treatment for solid tumor hematologic malignancies (cancer)

  • Severe primary immunodeficiency

  • Advanced or untreated HIV

  • Active treatment with high dose corticosteroids, alkylating agents, antimetabolites, TNF blockers, and other biologic agents

  • Asplenia and chronic renal disease can be considered if condition is severe

 

Additional doses can be administered to Pfizer recipients ages 5+ or Moderna recipients ages 18+. Online scheduling for 3rd doses for immunocompromised individuals 5-11 available now.

 

Moderately to severely immunocompromised individuals have been approved for a booster shot 5 months after a Pfizer 3rd dose for individuals ages 12+ or 5 months after a Moderna 3rd dose for individuals ages 18+.  

 

For eligible individuals, please schedule an appointment today.